Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lundbeck eyes new drugs as key antidepressant fades
Reuters
Wednesday, May 2, 2012 - 11:18am
tags:
antidepressants, Lundbeck, earnings
Wednesday's Bio Pharma Drug Approval And Catalyst Watch List
Seeking Alpha
Wednesday, May 2, 2012 - 11:16am
tags:
Amarin, iBio, Lexicon Pharmaceuticals, MedicNova
26 Drugs Facing FDA Approval in 2012
TheStreet.com
Wednesday, May 2, 2012 - 11:12am
tags:
drug approvals, FDA, Regeneron, ONYX Pharmaceuticals, Pfizer, Celgene, Arena Pharmaceuticals, Alexa, Gilead, Merck, Ironwood, Vivus, Navidea Biopharmaceuticals, NPS Pharmaceuticals, Raptor Pharmaceuticals, Santarus, Biogen Idec
Vical: An Update On My $3 Biotech Lottery Ticket
Seeking Alpha
Wednesday, May 2, 2012 - 11:08am
tags:
Vical, earnings
Is Human Genome Sciences the Perfect Stock?
Motley Fool
Wednesday, May 2, 2012 - 11:02am
tags:
Human Genome Sciences
PhRMA speaks out against FDA biosimilar flexibility
in-Pharma Technologist
Wednesday, May 2, 2012 - 11:01am
tags:
PhRMA, biosimilars, FDA
Drug and device trials vary in size, quality: study
Reuters
Wednesday, May 2, 2012 - 11:00am
tags:
clinical trials
Pfizer Pays $450M To BYU Over Celebrex Spat
Pharmalot
Wednesday, May 2, 2012 - 10:57am
tags:
Celebrex, BYU, Pfizer
Heart Stopper: Mirapex And Undisclosed Data
Pharmalot
Wednesday, May 2, 2012 - 10:52am
tags:
Mirapex, Boehringer Ingelheim, restless legs syndrome
Forbes Earnings Preview: Dendreon
Forbes
Wednesday, May 2, 2012 - 10:50am
tags:
Dendreon, earnings
Pfizer CEO Read: We'll pay $4B for mid-size drug companies, Reuters reports
Yahoo/Fly on the Wall
Wednesday, May 2, 2012 - 9:21am
tags:
Pfizer, Pharma CEOs, Ian Read, M&A
Novartis Drug for Smoker’s Cough Boosts Lung Function in Study
Bloomberg
Wednesday, May 2, 2012 - 9:20am
tags:
Novartis, smoker's cough, NVA237
Elan Misses 1Q EPS, Revenues Rise
Yahoo/Zacks.com
Wednesday, May 2, 2012 - 9:18am
tags:
Elan, earnings
Juicy Details From Tang Capital's Lawsuit Against Savient Pharma
TheStreet.com
Tuesday, May 1, 2012 - 10:20pm
tags:
Savient
Valeant: Why Investors Are Getting In Now
Seeking Alpha
Tuesday, May 1, 2012 - 10:18pm
tags:
Valeant Pharmaceuticals, Questcor, Vertex Pharmaceuticals
Ampio: Heading in the Right Direction
Motley Fool
Tuesday, May 1, 2012 - 10:15pm
tags:
Ampio Pharmaceuticals
U.S. FDA approves Pfizer/Protalix drug for Gaucher
Reuters
Tuesday, May 1, 2012 - 10:13pm
tags:
Pfizer, Protalix BioTherapeutics, FDA, Gaucher disease
Allergan draws puts ahead of earnings
Yahoo/optionMONSTER
Tuesday, May 1, 2012 - 12:39pm
tags:
earnings, Allergan
Avastin, Lucentis equally effective at improving vision, big study finds
Fierce Pharma
Tuesday, May 1, 2012 - 12:39pm
tags:
Lucentis, Avastin, Roche, Novartis, macular degeneration
MannKind Rents Out a Drug Program
Motley Fool
Tuesday, May 1, 2012 - 12:37pm
tags:
MannKind, Tolero, Btk inhibitors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.